Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing and able to give spoken and written consent to take part in the study
- Men and women aged 18 years or older
- People whose body mass index (BMI) falls within a specific range — either 18.5–24.9 (lean/healthy weight range) for the control group, or 35–50 (higher weight range) for the group scheduled for gastric bypass surgery
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unwilling or unable to follow the study instructions
- People who are pregnant
- People with significant digestive or gut problems
- People who use tobacco products
- People who have consumed alcohol within two days before their study visit
- People who have had an active cancer diagnosis within the past 5 years
- People who use dietary supplements that affect inflammation (such as fish oil) and are not willing to stop taking them one week before their study visits
- People who have an existing heart or metabolic condition, or who take medication related to such conditions (for example, blood pressure medication or insulin for diabetes)
- People who have an existing inflammatory condition, or who take medication related to such a condition
- People who have an increased tendency to bleed or who take blood-thinning medication
- For the gastric bypass group only: people who have lost more than 8% of their body weight since being referred for surgery, or more than 3% of their body weight in the four months leading up to surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emma Börgeson, Dr., PhD, MSc, University of Aarhus
Phone: +45 9352 2984
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Whole blood ROS prooduction; Whole blood ROS production
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.